Ignyte Acquisition Total Debt vs. Shares Owned By Insiders
| PKBODelisted Stock | USD 1.31 0.09 6.43% |
For Ignyte Acquisition profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ignyte Acquisition to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ignyte Acquisition Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ignyte Acquisition's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ignyte Acquisition Corp over time as well as its relative position and ranking within its peers.
Ignyte |
Ignyte Acquisition Corp Shares Owned By Insiders vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Ignyte Acquisition's current stock value. Our valuation model uses many indicators to compare Ignyte Acquisition value to that of its competitors to determine the firm's financial worth. Ignyte Acquisition Corp is rated top company in total debt category among its peers. It also is considered to be number one stock in shares owned by insiders category among its peers . The ratio of Total Debt to Shares Owned By Insiders for Ignyte Acquisition Corp is about 184,024 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ignyte Acquisition by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ignyte Acquisition's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Ignyte Total Debt vs. Competition
Ignyte Acquisition Corp is rated top company in total debt category among its peers. Total debt of Biotechnology industry is at this time estimated at about 35.4 Million. Ignyte Acquisition retains roughly 6.22 Million in total debt claiming about 18% of stocks in Biotechnology industry.
Ignyte Shares Owned By Insiders vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Ignyte Acquisition |
| = | 6.22 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Ignyte Acquisition |
| = | 33.80 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Ignyte Shares Owned By Insiders Comparison
Ignyte Acquisition is currently under evaluation in shares owned by insiders category among its peers.
Ignyte Acquisition Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Ignyte Acquisition, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ignyte Acquisition will eventually generate negative long term returns. The profitability progress is the general direction of Ignyte Acquisition's change in net profit over the period of time. It can combine multiple indicators of Ignyte Acquisition, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency . Peak Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.
Ignyte Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Ignyte Acquisition. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ignyte Acquisition position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ignyte Acquisition's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Ignyte Acquisition without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Use Investing Themes to Complement your Ignyte Acquisition position
In addition to having Ignyte Acquisition in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Management Thematic Idea Now
Health Management
Major hospitals and healthcare providers. The Health Management theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Management Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Ignyte Pink Sheet
If you are still planning to invest in Ignyte Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ignyte Acquisition's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |